Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Non Operating Income (2016 - 2025)

Apyx Medical (APYX) has disclosed Non Operating Income for 10 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income fell 49.28% year-over-year to -$2.3 million, compared with a TTM value of -$4.4 million through Dec 2025, up 30.89%, and an annual FY2025 reading of -$4.4 million, up 1.64% over the prior year.
  • Non Operating Income was -$2.3 million for Q4 2025 at Apyx Medical, down from -$1.0 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $622000.0 in Q2 2022 and bottomed at -$2.9 million in Q3 2024.
  • Average Non Operating Income over 5 years is -$546611.1, with a median of -$186000.0 recorded in 2021.
  • The sharpest move saw Non Operating Income soared 1327.03% in 2023, then tumbled 652.65% in 2024.
  • Year by year, Non Operating Income stood at -$184000.0 in 2021, then soared by 110.33% to $19000.0 in 2022, then skyrocketed by 2678.95% to $528000.0 in 2023, then plummeted by 388.26% to -$1.5 million in 2024, then tumbled by 49.28% to -$2.3 million in 2025.
  • Business Quant data shows Non Operating Income for APYX at -$2.3 million in Q4 2025, -$1.0 million in Q3 2025, and -$1.1 million in Q1 2025.